L. Verhoog

发表

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammography

Theo van der Kwast, T. H. van der Kwast, J. Klijn, 2002, International journal of cancer.

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

J. Klijn, C. Seynaeve, A. V. D. van den Ouweland, 2004, European journal of cancer.

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

C. Seynaeve, J. Klijn, E. Meijers-Heijboer, 2000, British Journal of Cancer.

One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

J. Klijn, C. Seynaeve, C. Brekelmans, 2002, Breast Cancer Research and Treatment.

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing

J. Klijn, C. Seynaeve, M. Niermeijer, 2003, American journal of medical genetics. Part A.

Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors

T. H. van der Kwast, J. Klijn, M. Timmermans, 2003, Breast Cancer Research and Treatment.

Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.

J. Klijn, E. Berns, P. Devilee, 2001, European journal of cancer.

A Dutch patient presenting with a rare clinical syndrome

W. Vrijland, L. Verhoog, G. Elshout, 2010, Gut.

Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.

C. Seynaeve, A. Eggermont, J. Klijn, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Should internal mammary chain (IMC) sentinel node biopsy be performed? Outcome in 90 consecutive non-biopsied patients with a positive IMC scintigraphy.

A. Y. de Kanter, A. V. van Geel, A. Eggermont, 2008, Breast.

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

J. Klijn, C. Seynaeve, A. V. D. van den Ouweland, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Cancer Screening in High-Risk Women

J. Klijn, H. Meijers-Heijboer, C. Seynaeve, 1999, Disease Markers.

Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer.

A. Hollestelle, J. Martens, M. Hooning, 2015, Human pathology.

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer

J. Foekens, J. Klijn, A. Sieuwerts, 2013, Breast Cancer Research and Treatment.

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

J. Klijn, H. Meijers-Heijboer, C. Seynaeve, 2001, The New England journal of medicine.

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

J. Klijn, P. Devilee, C. Seynaeve, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival of patients with breast cancer and BRCA1 mutations

J. Klijn, H. Meijers-Heijboer, C. Brekelmans, 1998, The Lancet.

Molecular diagnostics of a single multifocal non-small cell lung cancer case using targeted next generation sequencing

W. Dinjens, W. Hanselaar, L. Verhoog, 2013, Virchows Archiv.

Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group

J. Hartman, P. V. van Diest, C. Denkert, 2021, Cancers.

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

J. Klijn, P. Devilee, A. Ouweland, 1998, The Lancet.